Curcumin: An Anti-Inflammatory Molecule from a Curry Spice on the Path to Cancer Treatment

被引:534
作者
Basnet, Purusotam [1 ]
Skalko-Basnet, Natasa [1 ]
机构
[1] Univ Tromso, Drug Transport & Delivery Res Grp, Dept Pharm, N-9037 Tromso, Norway
关键词
curcumin; cancer; anti-oxidant; anti-inflammatory; nanoparticles; FACTOR-KAPPA-B; CHEMOPREVENTIVE AGENT CURCUMIN; LIPOSOME-ENCAPSULATED CURCUMIN; RADICAL SCAVENGING ACTIVITY; NITRIC-OXIDE SYNTHASE; I CLINICAL-TRIAL; CYCLOOXYGENASE-2; EXPRESSION; HEME OXYGENASE-1; DIETARY ANTIOXIDANTS; ANTICANCER ACTIVITY;
D O I
10.3390/molecules16064567
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Oxidative damage and inflammation have been pointed out in preclinical studies as the root cause of cancer and other chronic diseases such as diabetes, hypertension, Alzheimer's disease, etc. Epidemiological and clinical studies have suggested that cancer could be prevented or significantly reduced by treatment with anti-oxidant and anti-inflammatory drugs, therefore, curcumin, a principal component of turmeric (a curry spice) showing strong anti-oxidant and anti-inflammatory activities, might be a potential candidate for the prevention and/or treatment of cancer and other chronic diseases. However, curcumin, a highly pleiotropic molecule with an excellent safety profile targeting multiple diseases with strong evidence on the molecular level, could not achieve its optimum therapeutic outcome in past clinical trials, largely due to its low solubility and poor bioavailability. Curcumin can be developed as a therapeutic drug through improvement in formulation properties or delivery systems, enabling its enhanced absorption and cellular uptake. This review mainly focuses on the anti-inflammatory potential of curcumin and recent developments in dosage form and nanoparticulate delivery systems with the possibilities of therapeutic application of curcumin for the prevention and/or treatment of cancer.
引用
收藏
页码:4567 / 4598
页数:32
相关论文
共 173 条
[1]   Synthesis and biological evaluation of novel curcumin analogs as anti-cancer and anti-angiogenesis agents [J].
Adams, BK ;
Ferstl, EM ;
Davis, MC ;
Herold, M ;
Kurtkaya, S ;
Camalier, RF ;
Hollingshead, MG ;
Kaur, G ;
Sausville, EA ;
Rickles, FR ;
Snyder, JP ;
Liotta, DC ;
Shoji, M .
BIOORGANIC & MEDICINAL CHEMISTRY, 2004, 12 (14) :3871-3883
[2]  
Aggarwal B.B., 2007, MOL TARGET THERAPEUT
[3]   Molecular targets of dietary agents for prevention and therapy of cancer [J].
Aggarwal, BB ;
Shishodia, S .
BIOCHEMICAL PHARMACOLOGY, 2006, 71 (10) :1397-1421
[4]  
Aggarwal BB, 2003, ANTICANCER RES, V23, P363
[5]   Nuclear factor-κ-B:: The enemy within [J].
Aggarwal, BB .
CANCER CELL, 2004, 6 (03) :203-208
[6]   Pro-oxidant, anti-oxidant and cleavage activities on DNA of curcumin and its derivatives demethoxycurcumin and bisdemethoxycurcumin [J].
Ahsan, H ;
Parveen, N ;
Khan, NU ;
Hadi, SM .
CHEMICO-BIOLOGICAL INTERACTIONS, 1999, 121 (02) :161-175
[7]   Preparation, characterization, in vitro drug release and biological studies of curcumin loaded dextran sulphate-chitosan nanoparticles [J].
Anitha, A. ;
Deepagan, V. G. ;
Rani, V. V. Divya ;
Menon, Deepthy ;
Nair, S. V. ;
Jayakumar, R. .
CARBOHYDRATE POLYMERS, 2011, 84 (03) :1158-1164
[8]  
[Anonymous], 1996, J Cell Biochem Suppl, V26, P72
[9]  
Aukunuru J., 2009, Int J Drug Dev Res, V1, P37
[10]   Expression of protective genies in human renal allografts: A regulatory response to injury associated with graft rejection [J].
Avihingsanon, Y ;
Ma, NL ;
Csizmadia, E ;
Wang, C ;
Pavlakis, M ;
Giraldo, M ;
Strom, TB ;
Soares, MP ;
Ferran, C .
TRANSPLANTATION, 2002, 73 (07) :1079-1085